FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

785688002: Carbidopa anhydrous (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3767988015 Carbidopa anhydrous en Synonym Active Entire term case insensitive SNOMED CT core module
3767989011 Carbidopa anhydrous (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa anhydrous Has disposition Dihydroxyphenylalanine decarboxylase inhibitor true Inferred relationship Existential restriction modifier
Carbidopa anhydrous Is a Dihydroxyphenylalanine true Inferred relationship Existential restriction modifier
Carbidopa anhydrous Is modification of Carbidopa true Inferred relationship Existential restriction modifier
Carbidopa anhydrous Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Carbidopa anhydrous Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Carbidopa anhydrous Inferred relationship Existential restriction modifier 2

This concept is not in any reference sets

Back to Start